Immunotoxins and other conjugates: pre-clinical studies

Mini Rev Med Chem. 2004 Jun;4(5):563-83. doi: 10.2174/1389557043403864.

Abstract

A wide variety of conjugates containing RIPs, of either chemical or recombinant type, have been made and tested against dangerous cells in vitro and in animal models. Many of these pre-clinical studies will be reviewed here dividing them on the basis of the target cell and the surface molecule specifically recognized.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / immunology
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / toxicity
  • Drug Evaluation, Preclinical
  • Humans
  • Immunotoxins / adverse effects
  • Immunotoxins / immunology
  • Immunotoxins / pharmacology
  • Immunotoxins / toxicity*
  • Proteins / adverse effects
  • Proteins / immunology
  • Proteins / pharmacology
  • Proteins / toxicity*
  • Ribosomes / drug effects
  • Sensitivity and Specificity

Substances

  • Antineoplastic Agents
  • Immunotoxins
  • Proteins